CytoMed Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GDTC and other ETFs, options, and stocks.About GDTC
CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments.
CEOWee Kiat Tan, PhD
CEOWee Kiat Tan, PhD
Employees43
Employees43
HeadquartersSingapore, Central Singapore
HeadquartersSingapore, Central Singapore
Founded2018
Founded2018
Employees43
Employees43
GDTC Key Statistics
Market cap12.32M
Market cap12.32M
Price-Earnings ratio-4.41
Price-Earnings ratio-4.41
Dividend yield—
Dividend yield—
Average volume21.59K
Average volume21.59K
High today$1.06
High today$1.06
Low today$1.01
Low today$1.01
Open price$1.01
Open price$1.01
Volume3.32K
Volume3.32K
52 Week high$3.68
52 Week high$3.68
52 Week low$0.7282
52 Week low$0.7282
Stock Snapshot
The current CytoMed Therapeutics(GDTC) stock price is $1.06, with a market capitalization of 12.32M. The stock trades at a price-to-earnings (P/E) ratio of -4.41.
During the trading session on 2026-03-11, CytoMed Therapeutics(GDTC) shares reached a daily high of $1.06 and a low of $1.01. At a current price of $1.06, the stock is +5.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 3.32K, compared to an average daily volume of 21.59K.
The stock's 52-week range extends from a low of $0.73 to a high of $3.68.
The stock's 52-week range extends from a low of $0.73 to a high of $3.68.
People also own
Based on the portfolios of people who own GDTC. This list is generated using Robinhood data, and it’s not a recommendation.